MedTrace Logo

Reliability and Validity of Three DT-TUG Protocols in MS

NCT07788859 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-08-27

No results posted yet for this study

Summary

Dual-tasking is performing two different tasks at the same time. For example, singing while cooking. Everyday activities often involve dual-task. In many researches evaluating dual-task performance in individuals with MS, it has been reported that individuals with severe disability, in particular, exhibit greater effort than healthy individuals. This increase in motor and cognitive dual-task performance in individuals with Multiple Sclerosis (MS) is associated with an increased risk of falls. There is a need for standardized, valid, and reliable assessment tools to evaluate dual-task performance in MS. The purpose of this study is to examine and compare the validity and reliability of the dual-task Timed Up and Go test administered using three different protocols.

Conditions

Interventions

OTHER

Intra-rater reliability analysis

For the intra-rater reliability analysis, three DTUG protocols will be evaluated at 7- to 10-day intervals.

OTHER

Inter-rater reliability analysis

For the inter-rater reliability analysis, three DTUG protocols will be administered to the same patient by two different physical therapists.

OTHER

Convergent validity

To assess convergent validity, the relationship between the measurements from the three DTUG protocols and the results of other balance and functional mobility tests will be examined.

Sponsors & Collaborators

  • Afyonkarahisar Health Sciences University

    lead OTHER

Principal Investigators

  • Hakan POLAT, PhD · Sanko University

  • Meltem UZUN, PhD · Sanko University

  • Suat EREL, PhD · Pamukkale University

  • Emel TAŞVURAN HORATA, PhD · Afyonkarahisar Health Sciences University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-16
Primary Completion
2026-09-14
Completion
2026-09-14

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07788859 on ClinicalTrials.gov